CB vs EBS
Chubb Ltd (CB) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CB and EBS stock pages for the full models.
Not investment advice.